alexa The Role of VEGF and VEGF Receptors in Carcinogenesis
ISSN: 2157-2518

Journal of Carcinogenesis & Mutagenesis
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Review Article

The Role of VEGF and VEGF Receptors in Carcinogenesis

Kevin J. French* and Kendall S. Frazier

GlaxoSmithKline, Department of Safety Assessment, UE0376, 709 Swedeland Rd. PO Box 1539, King of Prussia, USA

*Corresponding Author:
Kevin French
GlaxoSmithKline, Department of Safety Assessment
UE0376, 709 Swedeland Rd. PO Box 1539
King of Prussia, USA
Tel: 610-270-4973
Fax: 610-270-5150
E-mail: [email protected]

Received date: June 30, 2011; Accepted date: July 16, 2011; Published date: July 18, 2011

Citation: French KJ, Frazier KS (2011) The Role of VEGF and VEGF Receptors in Carcinogenesis. J Carcinogene Mutagene S2:002. doi: 10.4172/2157-2518.S2-002

Copyright: © 2011 French KJ, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.



The vascular endothelial growth factor (VEGF) family and its associated cognate receptors are critical components of angiogenesis, the process of new blood vessel formation. Under normal conditions, angiogenesis supports organism development and tissue homeostasis in a tightly controlled fashion. However, in the tumor microenvironment, several conditions, such as hypoxia and unchecked growth factor expression can lead to tumor angiogenesis, enabling endothelial proliferation and vessel assembly, which support cancer growth. Not only does tumor angiogenesis enable tumor proliferation, but its imbalance of regulators cause abnormal vascular structure, which can increase chemoresistance during therapy. Lymphangiogenesis, or the metastases-driven angiogenesis in the lymphatic system, has recently been identified as an essential process for tumor spread to lymph nodes and is driven through unique members of the VEGF signaling pathway family. Inhibition of tumor angiogenesis as an anti-cancer therapeutic strategy has resulted in the development of several recently approved drugs, unfortunately accompanied by angiogenic-related safety issues and off-target associated liabilities unique to individual drug profile. This review summarizes the role of the VEGF and VEGFR families in tumor biology and the therapies available that target these angiogenic pathways.


Share This Page

Additional Info

Loading Please wait..
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals


[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version